Poliomyelitis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2912A80.4A80.2A80.3
Who is this for?
Show terms as
8Active trials57Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Poliomyelitis (commonly known as polio) is an acute infectious disease caused by the poliovirus, a human enterovirus belonging to the Picornaviridae family. The virus is transmitted primarily through the fecal-oral route and initially replicates in the oropharynx and gastrointestinal tract before potentially invading the central nervous system. While the majority of poliovirus infections are asymptomatic or cause only mild flu-like illness, in a small percentage of cases the virus destroys motor neurons in the spinal cord and brainstem, leading to acute flaccid paralysis. The disease predominantly affects the lower extremities, though any voluntary muscle group can be involved, including respiratory muscles, which can be life-threatening. Key clinical features of paralytic poliomyelitis include asymmetric acute flaccid paralysis, muscle weakness, loss of reflexes, and muscle atrophy. The disease can present in several forms: spinal poliomyelitis (affecting limb muscles), bulbar poliomyelitis (affecting cranial nerves and respiratory centers), or bulbospinal poliomyelitis (a combination of both). Initial symptoms often include fever, fatigue, headache, neck stiffness, and limb pain, followed by rapid onset of weakness. Decades after the acute infection, some survivors develop post-polio syndrome, characterized by new progressive muscle weakness, fatigue, and pain. There is no specific antiviral treatment for poliomyelitis. Management is supportive and includes physical therapy, orthopedic interventions, respiratory support when needed, and rehabilitation to maximize functional recovery. Prevention through vaccination remains the cornerstone of disease control. Two highly effective vaccines exist: the inactivated poliovirus vaccine (IPV, Salk vaccine) and the oral poliovirus vaccine (OPV, Sabin vaccine). Global vaccination campaigns led by the Global Polio Eradication Initiative have reduced wild poliovirus cases by over 99% since 1988, though the disease has not yet been fully eradicated worldwide.

Clinical phenotype terms— hover any for plain English:

ParalysisHP:0003470Hypoplasia of the musculatureHP:0009004Muscle flaccidityHP:0010547Abnormal skeletal muscle morphologyHP:0011805
Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Jan 2026the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines

China National Biotec Group Company Limited

TrialNOT YET RECRUITING
Dec 2025A Study to Evaluate the Mucosal Intestinal Immunity to Poliovirus Type-2 of nOPV2 at Birth Dose in Healthy IPV Vaccinated Infants

Fidec Corporation — PHASE3

TrialNOT YET RECRUITING
Nov 2025Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine

Sinovac Biotech Co., Ltd — PHASE4

TrialRECRUITING
Nov 2025Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation

PATH — PHASE2

TrialRECRUITING
Sep 2025Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations

Sinovac Biotech Co., Ltd — PHASE4

TrialRECRUITING
Jan 2025Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV)

International Centre for Diarrhoeal Disease Research, Bangladesh — PHASE4

TrialNOT YET RECRUITING
Dec 2024A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers

CanSino Biologics Inc. — PHASE1, PHASE2

TrialRECRUITING
Nov 2024Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines

PATH — PHASE1, PHASE2

TrialRECRUITING
Jun 2024Phase IV Study of Concomitant Administration of the sIPV and HepA

Institute of Medical Biology, Chinese Academy of Medical Sciences — PHASE4

TrialNOT YET RECRUITING
May 2024Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV

Serum Institute of India Pvt. Ltd. — PHASE3

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Poliomyelitis.

8 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

8 recruitingView all trials with filters →
Phase 42 trials
Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine
Phase 4
Actively Recruiting
· Sites: Kawit, Cavite; Iloilo City +1 more
Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations
Phase 4
Actively Recruiting
· Sites: Dingxi, Gansu; Lanzhou, Gansu +1 more · Age: 050 yrs
Phase 22 trials
Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation
Phase 2
Actively Recruiting
PI: Xavier Saez Llorens, MD (Cevaxin) · Sites: Panama City; Panama City +1 more
Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh
Phase 2
Actively Recruiting
PI: K. Zaman, MBBS, MPH, PhD, FRCP (International Centre for Diarrhoeal Disease Resear) · Sites: Dhaka · Age: 04 yrs
N/A2 trials
A Tool Kit to Improve Vaccine Confidence in the Philippines
N/A
Active
PI: Xiaolin Wei, PhD (University of Toronto) · Sites: Manila · Age: 1899 yrs
Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis
N/A
Active
· Sites: Chicago, Illinois · Age: 1880 yrs

Specialists

Showing 25 of 57View all specialists →
YH
Yuemei Hu
Specialist
PI on 6 active trials424 Poliomyelitis publications
IK
Ingrid Kromann
Specialist
PI on 4 active trials
KF
K. Zaman, MBBS, MPH, PhD, FRCP
Specialist
PI on 1 active trial
VP
Vytautas Usonis, Prof
Specialist
PI on 1 active trial
EM
Edna Viegas, MD,PhD
Specialist
PI on 1 active trial
BI
Baxter BioScience Investigator
Specialist
PI on 7 active trials
YB
Yuemei Hu, Bachelor
Specialist
PI on 5 active trials
DM
Daniel Landi, MD
DURHAM, NC
Specialist
PI on 7 active trials
FM
Fengcai Zhu, Master
Specialist
PI on 3 active trials
EM
Edwin J Asturias, MD
AURORA, CO
Specialist
PI on 4 active trials
AM
Anshu Varma, MSc
FRESNO, CA
Specialist
PI on 1 active trial
PD
Peter Aaby, DMSc,Professor
Specialist
PI on 1 active trial
AP
Ane Fisker, MD, PhD
Specialist
PI on 2 active trials
MM
Miguel Galindo, MD
Specialist
PI on 1 active trial
AP
Aksel Jensen, PhD
Specialist
PI on 1 active trial
AP
Amabelia Rodrigues, Ph
Specialist
PI on 1 active trial
PH
Pan Hongxing
Specialist
PI on 1 active trial
KZ
Khalequ Zaman
Specialist
PI on 1 active trial
LS
Laxman P Shrestha
Specialist
PI on 1 active trial
NH
Neal A Halsey
BALTIMORE, MD
Specialist
PI on 1 active trial
QP
Qihan Li, Ph.D
Specialist
PI on 1 active trial
SG
Stella Gutierrez
FULLERTON, CA
Specialist
PI on 1 active trial
XS
Xavier Saez-Llorens
Specialist
PI on 1 active trial
FG
François Genêt
Specialist
PI on 1 active trial
ZF
Zijian Feng
Specialist
PI on 3 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Poliomyelitis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open PoliomyelitisForum →

No community posts yet. Be the first to share your experience with Poliomyelitis.

Start the conversation →

Latest news about Poliomyelitis

Disease timeline:

New recruiting trial: Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine

A new clinical trial is recruiting patients for Poliomyelitis

New recruiting trial: Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh

A new clinical trial is recruiting patients for Poliomyelitis

New recruiting trial: Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations

A new clinical trial is recruiting patients for Poliomyelitis

New recruiting trial: A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers

A new clinical trial is recruiting patients for Poliomyelitis

New recruiting trial: Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines

A new clinical trial is recruiting patients for Poliomyelitis

New recruiting trial: Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation

A new clinical trial is recruiting patients for Poliomyelitis

New recruiting trial: Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV

A new clinical trial is recruiting patients for Poliomyelitis

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Poliomyelitis

What is Poliomyelitis?

Poliomyelitis (commonly known as polio) is an acute infectious disease caused by the poliovirus, a human enterovirus belonging to the Picornaviridae family. The virus is transmitted primarily through the fecal-oral route and initially replicates in the oropharynx and gastrointestinal tract before potentially invading the central nervous system. While the majority of poliovirus infections are asymptomatic or cause only mild flu-like illness, in a small percentage of cases the virus destroys motor neurons in the spinal cord and brainstem, leading to acute flaccid paralysis. The disease predomina

Are there clinical trials for Poliomyelitis?

Yes — 8 recruiting clinical trials are currently listed for Poliomyelitis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Poliomyelitis?

25 specialists and care centers treating Poliomyelitis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.